Hypertension trials recruiting in New York

All Hypertension trials nationally

Cities in New York

Recruiting trials in New York

• A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
  NCT07218029 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• A Comparative, Randomized, Investigator-blind, Active-controlled, Parallel-group, Multicenter, Clinical Endpoint Study
  NCT07661329 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: Rochester
• A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
  NCT07285655 · Phase: Phase 3 · Ages: 18 Years to 80 Years · Sex: All (male and female) · New York: New York, Rochester
• A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
  NCT06742723 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: Albany, Buffalo, New York
• A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
  NCT07142356 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · New York: The Bronx
• A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
  NCT07481981 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · New York: Rochester
• Affect of Melatonin on Sleep and Cognition in Cirrhosis
  NCT07046429 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
  NCT07365332 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · New York: New York, Valhalla
• An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
  NCT06129240 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · New York: New York, Rochester
• BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
  NCT06059638 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New Hyde Park, New York, Rochester
• Clarifying the Optimal Application of SLT Therapy Trial
  NCT04967989 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: The Bronx
• Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
  NCT06402968 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female) · New York: Albany, New York
• Comparison of Intraocular Pressure Measurement With the Novel TonoVera Device With Other Commonly Used Devices
  NCT05523622 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: All (male and female) · New York: Buffalo
• DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
  NCT06388421 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · New York: New Hyde Park, New York, Rochester
• Digital Solutions to Reduce Maternal Morbidity and Mortality in Pregnant Refugee Women
  NCT06647511 · Phase: Not specified · Ages: 18 Years and older · Sex: Female · New York: New York
• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
  NCT07064473 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: Albany, Binghamton, Buffalo, New York
• EVE TRIAL , ALMA SYSTAM
  NCT06646653 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Female · New York: Brooklyn
• Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
  NCT06468202 · Phase: Phase 4 · Ages: 14 Years to 35 Years · Sex: Female · New York: New York
• Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
  NCT07179380 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)
  NCT07290244 · Phase: Phase 1 · Ages: 40 Years to 85 Years · Sex: All (male and female) · New York: New York
• Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
  NCT07090161 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: Mount Kisco, Rochester
• Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial
  NCT05924477 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: Buffalo
• Global Paradise System US Post Approval Study
  NCT06297291 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · New York: Albany, Brooklyn, Buffalo, New York
• Innovative Approaches to Hypertension Management in High-Risk Emergency Department Populations
  NCT07539597 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
  NCT07288398 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · New York: New York, Rochester
• Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
  NCT06911632 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: Buffalo, New York
• Non-Invasive Preeclampsia Screening and Biobank
  NCT06643741 · Phase: Not specified · Ages: 18 Years and older · Sex: Female · New York: New York
• Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
  NCT06274801 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · New York: New York, Rochester
• Partners in Control, Phase II: Using Remote Monitoring Technology With Community Health Workers to Support Hypertension Management for Latinx Patients
  NCT06730230 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
  NCT02249923 · Phase: Not specified · Ages: 1 Day to 21 Years · Sex: All (male and female) · New York: New York
• Pilocarpine Use After Kahook Goniotomy
  NCT03933631 · Phase: Phase 3 · Ages: 30 Years to 100 Years · Sex: All (male and female) · New York: The Bronx
• Predictors of Aspirin Failure in Preeclampsia Prevention
  NCT05709483 · Phase: Early Phase 1 · Ages: 18 Years to 45 Years · Sex: Female · New York: New York
• Pulmonary Hypertension Association Registry
  NCT04071327 · Phase: Not specified · Ages: 0 Years and older · Sex: All (male and female) · New York: New York, Rochester
• Randomized Controlled Trial of Two Mobile Health Strategies to Manage Postpartum Hypertension
  NCT07209254 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · New York: New York
• Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension
  NCT07511361 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New York: Staten Island
• THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
  NCT06559891 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years to 75 Years · Sex: All (male and female) · New York: Liverpool, New York
• The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease
  NCT07561034 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: Rochester
• To Study Ocular Outflow Dynamics of the Eye Using Intraoperative Tonographic Biometry and Assess Its Predictive Value in Improving Postoperative Outcomes.
  NCT07425496 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension
  NCT05884190 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · New York: Buffalo
• Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
  NCT04555161 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
  NCT06526195 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: Manhasset, New York, Rochester, The Bronx
• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
  NCT07181109 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: New Windsor, North Massapequa, Poughkeepsie, Riverhead